没有数据的规范化横截面网络建模:方法比较
1Department of Psychology, McGill University, Montreal, Canada.
Multivariate behavioral research
|September 17, 2025
概括
本研究比较了使用图形拉索 (glasso) 在网络建模中处理缺失数据的方法. 预期最大化算法与交叉验证证明了心理网络分析的最佳性能.
科学领域:
- 网络科学 网络科学
- 心理测量 心理测量
- 统计建模 统计建模
背景情况:
- 网络建模对于分析心理变量至关重要,通常使用规范化的高斯图形模型 (GGM) 与图形拉索 (glasso).
- 现有的处理失踪数据的方法是不发达的,这限制了有效的数据收集设计的使用.
- 计划的缺失数据设计可以减少参与者的负担,但需要强大的缺失数据处理技术.
研究的目的:
- 为了比较在图形拉索框架内处理缺失数据的三个不同的方法.
- 在不同的模拟条件下评估这些方法的性能,包括样本大小和缺失数据比例.
- 为分析缺乏观测的心理网络数据的研究人员提供实际指导.
主要方法:
- 在glasso之前使用和共变矩阵的两阶段估计方法.
- 单阶段方法将glasso与预期最大化 (EM) 算法结合起来,使用EBIC或交叉验证来调整参数选择.
- 一项模拟研究,评估不同样本大小,缺失数据比例和网络结构的性能,并补充了现实数据示例.
主要成果:
- 预期最大化 (EM) 算法与调整参数选择的交叉验证相结合,在评估的方法中表现最佳.
- 这三种比较方法都显示出可行性,特别是在样本规模较大,缺失数据比例较低的场景中.
- 该研究确定了在心理网络分析中选择适当的缺失数据处理技术的实际考虑因素.
结论:
- 具有交叉验证的EM算法提供了一个有前途的策略,用于解决图形激光网络分析中缺失的数据.
- 研究人员在选择心理网络分析方法时应考虑样本大小和缺失数据的流行率.
- 进一步的方法开发是有必要的,以提高复杂的网络模型中缺少数据的处理.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
561
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
561
Mechanistic Models: Compartment Models in Individual and Population Analysis
250
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
250
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
494
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
494
Statistical Methods for Analyzing Epidemiological Data
900
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
900
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
1.1K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
1.1K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
242
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
242


